Vioxx litigation update
Merck is named as defendant in 2,300 Vioxx-related lawsuits, including 4,600 plaintiff groups alleging personal injuries following the use of the COX-2 inhibitor. The first trials are scheduled for May 23 in Alabama and May 31 in Texas. Merck has $675 mil. in reserve to cover the legal costs associated with the withdrawal of Vioxx in September 2004 (1"The Pink Sheet" Jan. 31, 2005, p. 7)...
You may also be interested in...
Merck will take a $604 mil. charge in the fourth quarter to establish a reserve for its defense of Vioxx litigation, an amount roughly equivalent to Singulair quarterly sales
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.